September 7, 2022 — Accuray Incorporated announced the company is joining forces with Genolier Innovation Hub, a fully-owned subsidiary of AEVIS VICTORIA SA, in support of a unique new approach to improving patient care. Genolier Innovation Hub will unite companies from the medtech, pharma and biosciences sectors, physicians and scientists, under one roof, with the goal of bringing medical and technological advances to patients faster. The Hub is expected to open in early 2024.
Genolier Innovation Hub will be located in the heart of the Genolier Healthcare Campus in Genolier, Switzerland. The facility will offer different workspaces to meet the varied requirements of the participants including operating rooms to support simulation-based training, bunkers with radiation therapy systems for training, R&D and demonstration, and meeting rooms equipped with the most advanced technologies to host seminars, workshops and events. Accuray will leverage the Hub as a global training center where customers will have the opportunity to obtain hands-on training and learn about advanced radiation therapy techniques – using its CyberKnife and Radixact Systems – from renowned faculty.
The CyberKnife and Radixact Systems are radiation therapy devices that have been proven to deliver highly effective treatments for a broad range of tumors almost anywhere in the body. The systems include advanced functionality that make it easier and more efficient to administer extremely precise radiation treatments, even to targets that move, providing the medical care team with options for managing the full spectrum of cancer cases, from routine to complex and initial treatment to retreatment, and neurologic disorders. The two systems are successfully being used at the Clinique Générale-Beaulieu in Geneva, and the Radixact System will also be used at the Clinique de Genolier, both being flagship clinics of the Swiss Medical Network, AEVIS’s main shareholding.
“We are proud to lead the radiation therapy industry as an anchor for Genolier Innovation Hub. Our involvement is consistent with our focus on advancing patient care through investments in innovation in all aspects of our business, from our technology to clinical support and education,” said Suzanne Winter, president and chief executive officer of Accuray. “We look forward to partnering with Genolier Innovation Hub to usher in a new level of collaboration that speeds the progress made in patient-centric care. This is a long-term commitment for both companies.”
“Our philosophy is to put the patient at the heart of everything we do. This viewpoint is a key driver behind the new Genolier Innovation Hub which is designed to provide a forum for creating cross-sector relationships that drive unprecedented improvements in care,” said Antoine Hubert, Chairman of the Board of Genolier Innovation Hub and Delegate of the Board of Directors of AEVIS Victoria SA. “Accuray shares our vision and I am confident that by working together we can create a model that sets a new standard in the healthcare industry.”
For more information: www.accuray.com
May 08, 2024 
